Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Experimental and Therapeutic Medicine|May 2, 2022
Patterns of indolence in prostate cancer (Review)Minas Sakellakis, Laura Jacqueline Flores, Sumankalai RamachandranJournal of Analytical Toxicology|August 9, 2011
Determination of tapentadol (Nucynta®) and N-desmethyltapentadol in authentic urine specimens by ultra-performance liquid chromatography-tandem mass spectrometryJames A Bourland, Ayodele A Collins, Scot A Chester, et al.The Prostate|June 25, 2021
Prostate cancer cells survive anti-androgen and mitochondrial metabolic inhibitors by modulating glycolysis and mitochondrial metabolic activitiesHirak S Basu, Nathaniel Wilganowski, Samantha Robertson, et al.International Journal of Molecular Sciences|February 15, 2022
Identifying the Metabolic Signatures of PPARD-Overexpressing Gastric TumorsShivanand Pudakalakatti, Mark Titus, José S Enriquez, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 26, 2021
Estrogen Promotes Resistance to Bevacizumab in Murine Models of NSCLCSonia A Patel, Matthew H Herynk, Tina Cascone, et al.Cancer Prevention Research (Philadelphia, Pa.)|August 18, 2022
Targeting the mTOR Pathway for the Prevention of ER-Negative Breast CancerAbhijit Mazumdar, William M Tahaney, Jamal L Hill, et al.Cancer Research Communications|November 6, 2023
Monitoring Glucocorticoid Receptor in Plasma-derived Extracellular Vesicles as a Marker of Resistance to Androgen Receptor Signaling Inhibition in Prostate CancerEmanuela Gentile, Andrew W Hahn, Jian H Song, et al.Molecular Imaging and Biology|May 12, 2018
Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Alters Hyperpolarized Pyruvate to Lactate Conversion and Lactate Levels In VivoNiki Zacharias, Jaehyuk Lee, Sumankalai Ramachandran, et al.Proteomics|February 26, 2026
Imaging Mass Spectrometry-Based Assessment of ER, PR, and HER2 Protein Expression in Breast CancerKiran K Mangalaparthi, Daigo Gunji, Olajide E Olaleye, et al.Prostate Cancer and Prostatic Diseases|September 13, 2022
Characterization of prostate cancer adrenal metastases: dependence upon androgen receptor signaling and steroid hormonesMinas J Sakellakis, Andrew W Hahn, Sumankalai Ramachandran, et al.Pageof 2